ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 176 out of 1006

$623K Total Retail Price of All Prescriptions

Rank: 141 out of 1006

429 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 7,735 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 364 357 1 2
AMLODIPINE BESYLATE 347 326 2 4
ATORVASTATIN CALCIUM 324 306 3 5
LISINOPRIL 274 255 4 3
SIMVASTATIN 255 231 5 1
METFORMIN HCL 202 196 6 10
CRESTOR 189 177 7 18
HYDROCHLOROTHIAZIDE 186 184 8 11
PRAVASTATIN SODIUM 162 159 9 15
METOPROLOL TARTRATE 160 155 10 7
TAMSULOSIN HCL 137 136 11 23
OMEPRAZOLE 131 128 12 9
FUROSEMIDE 127 117 13 6
ATENOLOL 122 122 14 13
METOPROLOL SUCCINATE 117 113 15 12
LOSARTAN POTASSIUM 117 112 15 22
ALENDRONATE SODIUM 116 116 17 29
ALLOPURINOL 106 96 18 31
CYMBALTA 104 85 19 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 89 20 38
LOSARTAN-HYDROCHLOROTHIAZIDE 94 79 21 81
DIOVAN HCT 91 90 22 60
WARFARIN SODIUM 88 88 23 8
DONEPEZIL HCL 81 81 24 17
METFORMIN HCL ER 76 68 25 56
ZOLPIDEM TARTRATE 75 68 26 14
GABAPENTIN 75 64 26 20
SYNTHROID 74 74 28 42
GLIMEPIRIDE 73 73 29 50
VENLAFAXINE HCL ER 73 64 29 105
FINASTERIDE 68 68 31 76
MELOXICAM 67 58 32 67
NEXIUM 66 64 33 28
DOXAZOSIN MESYLATE 66 66 33 87
PANTOPRAZOLE SODIUM 63 63 35 32
CITALOPRAM HBR 63 51 35 24
SINGULAIR 60 60 37 82
ACTONEL 58 56 38 152
QUINAPRIL HCL 57 57 39 86
CARVEDILOL 55 55 40 36
BUPROPION XL 54 41 41 177
SPIRIVA 52 52 42 48
VERAPAMIL ER 52 47 42 116
LOVASTATIN 51 47 44 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.